3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
2
Completed
2
Terminated
1
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Thoracic
2
Head & Neck
2
Other solid neoplasm
1
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Head and Neck Neoplasms
2
Urologic Neoplasms
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Mesothelioma, Malignant
1
Lymphoma
1
Lung Neoplasms
1
Liver Neoplasms
1
Leukemia
1
Breast Neoplasms
1
Interventions
Cisplatin
28
toripalimab
14
Radiotherapy
12
Gemcitabine
12
Capecitabine
11
Radiotherapy, Intensity-Modulated
10
pembrolizumab
9
Surgical Procedures, Operative
9
Docetaxel
9
tislelizumab
8
Carboplatin
7
Drug Therapy
6
Blood Specimen Collection
6
anlotinib
5
Taxes
5
Paclitaxel
5
Nivolumab
5
Fluorouracil
5
Cetuximab
5
130-nm albumin-bound paclitaxel
5
Thyroxine
4
Magnetic Resonance Spectroscopy
4
Cyclophosphamide
4
trametinib
3
sintilimab
3
camrelizumab
3
Radiation
3
Observation
3
Injections
3
Immune Checkpoint Inhibitors
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Not yet recruiting
×
Tissue Banks
×
Head & Neck
×
Clear all
NCT07550049
2026-04-24
COMETH
University of Kansas Medical Center
Not yet recruiting
110 enrolled
NCT06827639
2025-02-14
FUTURE
Assistance Publique Hopitaux De Marseille
Not yet recruiting
640 enrolled